Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
Journal of Clinical Pharmacology - United States
doi 10.1002/jcph.759
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 10, 2016
Authors
Publisher
Wiley